TL;DR
This study investigated the impact of a mobile health (mHealth) application combined with traditional outpatient follow-up on the health outcomes of chronic kidney disease (CKD) patients. The findings suggest that this hybrid approach significantly improves certain laboratory markers, though it doesn't show a significant difference in mortality or renal replacement therapy rates compared to traditional follow-up alone.
What Problem Does This Paper Address?
Chronic Kidney Disease (CKD) is a growing global health concern with significant morbidity and healthcare costs. Effective management, particularly patient self-management, is crucial for slowing disease progression and preventing complications. While mobile applications have shown promise in aiding self-management for various chronic conditions, their long-term effectiveness in outpatient CKD management, especially when integrated with traditional care, remained underexplored. This paper aims to fill that gap by evaluating a specific mHealth intervention in a retrospective cohort study.
Methods
The study employed a retrospective cohort design, comparing two groups of CKD patients (stages 1-5, not on renal replacement therapy):
- APP + Outpatient Follow-up Group: Patients used a mobile application ("Suyi APP") at least once a month and had traditional outpatient follow-ups at least every three months.
- Traditional Outpatient Follow-up Group: Patients received traditional outpatient follow-ups at least every three months without using the mHealth app.
The "Suyi APP" was developed using an agile model and incorporated modules for personal information management, task assignment, appointment reminders, physiological assessments, health education, and risk alerts. The app aimed to simplify patient-physician communication and enhance home self-management.
To account for baseline differences between the groups, the researchers used Inverse Probability Treatment Weighting (IPTW). This statistical technique creates a "pseudo-sample" where the groups are more comparable across various baseline characteristics, allowing for a more robust comparison of outcomes.
Outcomes measured included:
- Laboratory data: eGFR, serum creatinine, uric acid, calcium, phosphorus, sodium, triglycerides, hemoglobin, etc.
- All-cause mortality.
- Renal replacement therapy (RRT) incidence: including hemodialysis (HD), peritoneal dialysis (PD), and renal transplantation (RT).
- Use of temporary dialysis catheters (as an indicator of urgent dialysis initiation).
Datasets
The study utilized data from the CKD Management Center's in-hospital CKD management information system. This system collected patient data from January 2015 to December 2019 for initial enrollment and followed up until December 2022. The study extracted data for 6015 eligible patients who met inclusion criteria. No new benchmark datasets were introduced.
Key Insights and Ideas
- Hybrid Approach Benefits Specific Markers: While the mHealth app didn't significantly alter mortality or the need for renal replacement therapy, it did lead to notable improvements in key laboratory indicators like Phosphorus, Sodium, Triglyceride, and Hemoglobin. This suggests the app is effective in influencing certain physiological parameters related to CKD management.
- Importance of Traditional Follow-up for Advanced CKD: For patients in advanced CKD stages (4-5), the study emphasizes the continued necessity of frequent face-to-face outpatient follow-ups. This is crucial for preparing them for renal replacement therapy and making informed treatment decisions.
- Reducing Urgent Dialysis Initiation: The study found that the traditional outpatient follow-up group had a lower incidence of using temporary catheters for initial hemodialysis, suggesting better preparation for RRT in this group.
- App as a Complement, Not Replacement: The findings highlight that mHealth apps are most effective when used in conjunction with, rather than as a complete replacement for, traditional clinical care. The app enhances patient engagement and provides valuable data, but clinical expertise remains vital, especially for complex decisions like RRT.
Key Results
- Laboratory Improvements: The APP+outpatient group showed significant improvements in Phosphorus, Sodium, Triglyceride, and Hemoglobin compared to the traditional outpatient group (P<.05). eGFR also increased in the APP+outpatient group while decreasing in the traditional group.
- Mortality: After IPTW matching, there were 34 deaths (1.4%) in the APP+outpatient group and 46 deaths (1.6%) in the traditional outpatient group. This difference was not statistically significant (P=.49).
- Renal Replacement Therapy (RRT): After matching, overall RRT incidence was comparable between the groups (APP+outpatient: 190 cases, 7.6%; traditional: 245 cases, 8.6%), with no significant difference (P=.23).
- Temporary Dialysis Catheter Use: Before matching, the APP+outpatient group had a significantly higher rate of temporary catheter use (24.1%) compared to the traditional group (13.7%) (P<.001). After matching, this difference persisted, with the APP+outpatient group showing a 19.1% higher rate (P<.001). This finding is somewhat counterintuitive to the goal of reducing urgent dialysis.
Limitations and Future Work
The authors acknowledge several limitations:
- Single-Center Observational Study: The findings may not be generalizable to other populations or healthcare systems. The long-term efficacy of the app intervention could not be definitively demonstrated.
- Digital Literacy and Accessibility: Many elderly patients may struggle with using smartphone apps, and varying levels of cultural literacy can impact knowledge acquisition.
- Data Collection: The study relied on data extraction from existing systems, which might have inherent limitations.
Future directions suggested include:
- Larger Cohort Studies: Investigating the long-term effects of app intervention in a larger, more diverse patient population.
- Developing Decision Support Tools: Creating sophisticated digital tools to aid patients in making critical decisions about renal replacement therapy, particularly for stages 4-5 CKD.
- Exploring Telemedicine Integration: Further research into the integration of advanced analytics and artificial intelligence within mobile applications to personalize patient care.
- Investigating Patient Willingness: Understanding and addressing factors influencing patient acceptance and consistent use of mHealth applications.
Summary updated